Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

¾ç¼º°ú ¾Ç¼º À§½ÊÀÌÁöÀå ÁúȯÀ¸·Î ºÎºÐÀ§ÀýÁ¦¼ú ÈÄ ¹ß»ýÇÑ ÀÜ·ùÀ§¾ÏÀÇ ÀÓ»óº´¸®ÇÐÀû Ư¼º°ú ¿¹ÈÄ Clinicopathologic Features and Prognosis of Gastric Remnant Cancer after Partial Gastrectomy for Benign and Malignant Gastric Lesions

´ëÇѾÏÇÐȸÁö 1997³â 29±Ç 6È£ p.1076 ~ 1084
¼Ò¼Ó »ó¼¼Á¤º¸
ÀÌÁÖÈ£/Joo Ho Lee ±è¼öÁø/À¯Ç×Á¾/¾çÇѱ¤/±èÁøº¹/Soo Jin Kim/Hang Jong Yu/Han-Kwang Yang/Jin-Pok Kim

Abstract

¼­·Ð
À§ ÀÜ·ùºÎ¿¡ ¹ß»ýÇÑ À§¼±¾ÏÀº Mayo ClinicÀÇ Sallow°¡ 1922³â¿¡ óÀ½À¸·Î ±â¼úÇÑ ÀÌÈÄ
1956 ³â¿¡ Helsingen°ú HillstadµîÀÌ ¾ç¼ºÁúȯÀ¸·Î À§½ÊÀÌÁöÀå ¼ö¼úÀ» ½ÃÇàÇÏ°í 5³âÀÌ»ó °æ
°úµÈ ÈÄ ÀÜ·ùºÎ À§¿¡ ¹ß»ýÇÑ À§¾ÏÀ¸·Î Á¤ÀÇÇÑ ¹Ù ÀÖ´Ù. ¼¼°èÀûÀ¸·Î À§¾ÏÀÇ ¹ß»ýºóµµ´Â Á¡Â÷
ÁÙ¾îµå´Â Ãß¼¼ÀÌÁö¸¸ 1950³â´ë ÀÌÈÄ À§ÀýÁ¦¼úÀÌ ¸¹ÀÌ ½ÃÇàµÇ°í Æò±Õ¼ö¸íÀÌ ±æ¾îÁö¸ç, Áø´Ü
¹æ¹ýÀÌ ¹ß´ÞÇÔ¿¡ µû¶ó ÀÜ·ùÀ§¾ÏÀÇ ºóµµ´Â Á¡Â÷ Áõ°¡ÇÏ°í ÀÖ´Â Ãß¼¼·Î ÀüüÀ§¾ÏÀÇ 0.8¡­8.9%
·Î º¸°íµÇ°í ÀÖ´Ù. ÀÌ·¸°Ô ³ÐÀº ¹üÀ§ÀÇ º¸°í´Â ÀûÀº ¼öÀÇ ¿¬±¸´ë»ó, ÀûÀýÇÑ ºñ±³±ºÀÇ ºÎÀç,
ºÒÃæºÐÇÑ È¯ÀÚ °ü¸®, ¼ÒÈ­¼º ±Ë¾ç¼ö¼úÀÇ ´Ù¾çÈ­¿¡ ±âÀÎÇÑ´Ù°í ÇÒ ¼ö ÀÖ´Ù. °ú°Å À§³»½Ã°æ µî
ÀÇ Áø´ÜÀû ¹æ¹ýÀÌ º¸ÆíÈ­µÇ°í ¹ß´ÞµÇÁö ¸øÇÑ ½Ã´ë¿¡´Â Á¶±â¹ß°ßÀÌ ¾î·Á¿ö º´º¯ÀÌ »ó´çÈ÷ Áø
ÇàµÈ »óÅ¿¡¼­ ¹ß°ßµÈ °æ¿ì°¡ ¸¹¾Æ¼­ ÀýÁ¦À²ÀÌ ³·¾Ò°í ¼ö¼ú±â¼ú»óÀÇ ¾î·Á¿ò, ¼ö¼ú ÈÄÀÇ ÇÕ
º´Áõ µîÀ¸·Î ÀÎÇÏ¿© ¿¹ÈÄ°¡ »ó´çÈ÷ ºÒ·®ÇÑ °ÍÀ¸·Î º¸°íµÇ¾î ¿ÔÀ¸³ª ÃÖ±ÙÀÇ º¸°í¿¡ ÀÇÇϸé
ºÐ¹®ºÎ À§¿¡ ¹ß»ýÇÑ ÀÏÂ÷ÀûÀÎ À§¾Ï¿¡ ºñÇØ Â÷ÀÌ°¡ ¾ø°Å³ª ¿ÀÈ÷·Á ¿¹ÈÄ°¡ ÁÁ´Ù´Â º¸°íµµ ÀÖ
´Ù. Çѱ¹°ú ÀϺ» µî À§¾Ï, ƯÈ÷ Á¶±âÀ§¾ÏÀÇ ¹ß»ýºóµµ°¡ ³ôÀº Áö¿ª¿¡¼­´Â 1950³â´ë ÀÌÈÄ À§¾Ï
À¸·Î ÀÎÇÏ¿© À§ÀÇ ºÎºÐÀýÁ¦°¡ ¸¹ÀÌ ½ÃÇàµÇ¾î ¿ÔÀ¸¸ç ÀÌ¿¡ µû¶ó ºÎºÐÀ§ÀýÁ¦¼úÀ» ¹ÞÀº ÈÄ ÀÜ
·ùºÎ À§ÀÇ ¾ÏÀÇ ¹ß»ý·üµµ Á¡Â÷ Áõ°¡ÇÏ°í ÀÖ´Ù. ´ëºÎºÐÀÇ ÀÜ·ùÀ§¾ÏÀº À§ÀýÁ¦¼ú ÈÄ 10³â ÀÌÈÄ
¿¡ ¹ß»ýÇÏ´Â ¹Ý¸é Àç¹ßÀ§¾ÏÀÇ 70% Á¤µµ°¡ ¼ö¼úÇÑ ÈÄ 3³â À̳»¿¡ Àç¹ßÇÏ°í ´ëºÎºÐÀÌ °£À̳ª
À§ÁÖÀ§ ¸²ÇÁÀý, º¹¸·¿¡ Àç¹ßÇÑ´Ù°í º¼ ¶§ À§ÀÇ ¾Ç¼ºº´º¯À¸·Î ºÎºÐÀ§ÀýÁ¦¸¦ ½ÃÇà ¹Þ°í 5³âÀÌ
»ó °æ°úÇÑ ÈÄ ÀÜ·ùºÎ À§¿¡ ¹ß»ýÇÑ À§¾ÏÀ» ÀÜ·ùÀ§¾ÏÀÇ ¹üÁÖ¿¡ Æ÷ÇÔ½ÃÄ×´Ù º» ±³½Ç¿¡¼­´Â ÀÜ
·ùºÐ À§¿¡ ¹ß»ýÇÑ À§¼±¾ÏÀÇ ÀÓ»óº´¸®ÇÐÀû Ư¼º°ú ¿¹ÈÄÀÎÀÚ¸¦ Á¶»çÇÏ°í, ÀÜ·ùÀ§¾ÏÀ» À§½ÊÀÌ
ÁöÀåÀÇ ¾ç¼ºÁúȯÀ¸·Î ¼ö¼úÇÑ µÚ ¹ß»ýÇÑ ÀÜ·ù À§¾Ï°ú ¾Ç¼ºÁúȯÀ¸·Î ¼ö¼úÇÑ µÚ ¹ß»ýÇÑ ÀÜ·ùÀ§
¾ÏÀÇ µÎ ±ºÀ¸·Î ³ª´©¾î ±× ÀÓ»ó»ó°ú ¿¹Èĸ¦ ºñ±³ ºÐ¼®ÇÔÀ¸·Î½á ÀÜ·ùºÎ À§¿¡ ´ëÇÑ ÃßÀûÁ¶»ç
¿Í ÀÜ·ùºÎ À§¿¡ ¹ß»ýÇÑ À§¼±¾ÏÀÇ ÀÚ¿¬°æ°ú Æľǰú Ä¡·á¹æħÀ» °áÁ¤Çϴµ¥ µµ¿òÀÌ µÇ°íÀÚ º»
¿¬±¸¸¦ ½ÃÇàÇÏ¿´´Ù.
#ÃÊ·Ï#
Purpose : Despite the decreasing incidence of primary gastric cancer, the incidence of
gastric cancer in the remnant stomach has been increasing. This study evaluated the
clinicopathologic features and prognosis of gastric cancer in the remnant stomach.
Methods and Materials : The clinicopathologic features and prognosis of 31 cases of
gastric cancers in the remnant stomach were evaluated retrospectively. 19 patients
among them underwent partial gastrectomy for benign gastroduodenal disease(Group I),
while 12 patients for malignant disease(Group ¥±) which were detected at least 5 years
after initial surgery and the clinicopathologic features and survival curves of two groups
were compared. The clinicopathologic (matures evaluated included age, sex, interval
between operations, type of operation, location of tumor, tumor size, Borrmann type,
depth of invasion, lymph node metastasis, distant metastasis, TNM stage, histologic
differentiation and Lauren classification.
Results : The median age was 59 years, 28 patients(90.3%) were male and median
time interval between operations was 15 years. Group I gastric remnant cancers were
detected late after initial gastrectomy and have a significant tendency toward lymph
node metastasis. Resection was carried out in 25 patients(81.0%) in which 22
patient(71.0%) underwent resections with curative intent. The overall 5 year survival
rate was 45.5% and no significant difference was observed between the survival curves
for patients with group I and group ¥±. Depth of invasion, lymph node metastasis,
distant metastasis, tumor size and curability of operation have prognostic significance in
univariate analysis and multivariate analysis performed with above 5 factors has
revealed that depth of invasion is the only independent prognostic factor
Conclusions : Both groups are similar in survival rate and clinicopathologic
characteristics except time interval between operations and lymph node metastasis. Early
detection by periodic endoscopic follow-up and radical resection is a reasonable policy as
a treatment of gastric remnant cancer.

Å°¿öµå

Gastric remnant cancer;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KoreaMed
KAMS